Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial-Reference-Cited by-同舟云学术

Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial

Published:2014-11 Issue:11 Volume:14 Page:1055-1064
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Baeten Jared M,Donnell Deborah,Mugo Nelly R,Ndase Patrick,Thomas Katherine K,Campbell James D,Wangisi Jonathan,Tappero Jordan W,Bukusi Elizabeth A,Cohen Craig R,Katabira Elly,Ronald Allan,Tumwesigye Elioda,Were Edwin,Fife Kenneth H,Kiarie James,Farquhar Carey,John-Stewart Grace,Kidoguchi Lara,Coombs Robert W,Hendrix Craig,Marzinke Mark A,Frenkel Lisa,Haberer Jessica E,Bangsberg David,Celum Connie

Funder

Bill & Melinda Gates Foundation

US National Institutes of Health

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference29 articles.

1. Prevention of HIV-1 infection with early antiretroviral therapy;Cohen;N Engl J Med,2011

2. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis;Donnell;Lancet,2010

3. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women;Baeten;N Engl J Med,2012

4. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N Engl J Med,2010

5. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana;Thigpen;N Engl J Med,2012

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breakthrough Acute HIV Infections among Pre-Exposure Prophylaxis Users with High Adherence: A Narrative Review;Viruses;2024-06-12

2. Establishing adherence–concentration–efficacy thresholds of TDF–FTC pre-exposure prophylaxis for HIV prevention in African women: a protocol for the Women TDF–FTC Benchmark Study;Frontiers in Reproductive Health;2024-05-27

3. Behavioral Health Disorders and HIV Incidence and Treatment Among Women;Women’s Behavioral Health;2024

4. Attitudes and Intentions toward Use of HIV Pre-Exposure Prophylaxis (PrEP) among Adults Receiving Treatment for Opioid Use;Substance Use & Misuse;2023-11-02

5. Attitudes Toward and Experiences With Discussing Pre-exposure Prophylaxis With Sexual Partners Among US Adolescents and Young Adults Living With HIV;Journal of Adolescent Health;2023-11